ImClone Investigational Site

Arlington, Texas 76014

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Colorectal Neoplasms, Metastases, Metastatic Pancreatic Cancer, Metastatic Renal Cell Carcinoma, Neoplasm

Studies at this site

• A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast Cancer — Completed
• A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma — Completed
• Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy — Completed
• Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer — Stopped early